参考文献/References:
[1] MENDOZA PR,GROSSNIKLAUS HE.The biology of retinoblastoma[J].Prog Mol Biol Transl Sci,2015,134:503-516.
[2] LIU J,ZHU Y.Recent advances in retinoblastoma treatment[J].Rec Adv Ophthalmol,2013,33(1):91-94.
刘瑾,朱豫.视网膜母细胞瘤的治疗进展[J].眼科新进展,2013,33(1):91-94.
[3] WANG S,HUANG J,HE J,WANG A,XU S,HUANG SF,et al.RPL41,a small ribosomal peptide deregulated in tumors,is essential for mitosis and centrosome integrity[J].Neoplasia,2010,12(3):284-293.
[4] WANG AY,XU S,ZHANG X,HE J,YAN D,YANG Z,et al.Ribosomal protein RPL41 induces rapid degradation of ATF4,a transcription factor critical for tumour cell survival in stress[J].J Pathol,2011,225(2):285-292.
[5] JIAO YJ,LIU JH.Methods of detection of apoptosis(review)[J].Chin J Neuroimmunol Neurol,2004,11(1):53-56.
矫毓娟,刘江红.细胞凋亡的检测方法(综述)[J].中国神经免疫学和神经病志,2004,11(1):53-56.
[6] XU C,XING YQ.Progress in research of chemotherapy and chemoresistance of retinoblastoma[J].Chin Ophthalmic Res,2010,28(11):1097-1100.
徐冲,邢怡桥.视网膜母细胞瘤的化学治疗及耐药性研究进展[J].眼科研究,2010,28(11):1097-1100.
[7] ROZPEDEK W,PYTEL D,MUCHA B,LESZCZYNSKA H,DIEHL JA,MAJSTEREK I.The role of the perk/eif2 alpha/atf4/chop signaling pathway in tumor progression during endoplasmic reticulum stress[J].Curr Mol Med,2016,16(6):533-544.
[8] MALHOTRA JD,KAUFMAN RJ.ER stress and its functional link to mitochondria:role in cell survival and death[J].Cold Spring Harb Perspect Biol,2011,3(9):a4424.
[9] ARAGON-CHING JB,DAHUT WL.VEGF inhibitors and prostate cancer therapy[J].Curr Mol Pharmacol,2009,2(2):161-168.
[10] ST H,CATHERINE A.Interactions between endothelial selectins and cancer cells regulate metastasis[J].Biosci (Landmark Ed),2011,16:3233-3251.
[11] JAIN S,CHAKRABORTY G,RAJA R,KALE S,KUNDU G.Prostaglandin E(2) regulates tumor angiogenesis in prostate cancer[J].Cancer Res,2008,68(19):7750-7759.
[12] IGARASHI T,IZUMI H,UCHIUMI T,NISHIO K,ARAO T,TANABE M,et al.Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines[J].Oncogene,2007,26(33):4749-4760.
[13] YU X,WARNER JR.Expression of a micro-protein[J].J Biol Chem,2001,276(36):3821-3382.
相似文献/References:
[1]刘瑾 朱豫.视网膜母细胞瘤的治疗进展[J].眼科新进展,2013,33(1):000.
[2]常海敏 杨磊 千新来.Calphostin C对人视网膜母细胞瘤细胞增殖的抑制作用[J].眼科新进展,2013,33(9):000.
[3]崔平 南娜 康洁 李军会 申景然.白藜芦醇对人视网膜母细胞瘤细胞侵袭能力的影响及机制研究[J].眼科新进展,2012,32(1):000.
[4]宋念艺 陈绪涛 张娴.B超、CT及MRI检查在视网膜母细胞瘤诊断中的价值[J].眼科新进展,2012,32(10):000.
[5]张千帆 刘瑞敏 穆红梅 郭洋 申飞 刘莹.白藜芦醇对视网膜母细胞瘤Y79细胞增殖的影响及其机制[J].眼科新进展,2012,32(11):000.
[6]兰兰 惠延年 曾光伟.微小RNA与磷酸化胞外信号调节激酶在视网膜母细胞瘤中的表达及其相关性分析[J].眼科新进展,2013,33(6):000.
[7]覃冬菊,唐罗生,游庆华,等.HSP27、增殖细胞核抗原在视网膜母细胞瘤中的表达[J].眼科新进展,2010,30(5):000.
[8]蒋永强 吴晓梅 连金贤.视网膜母细胞瘤术后23 a未复发1例[J].眼科新进展,2009,29(1):000.
[9]陈雪 李海平 张培 曹安民. 小胶质细胞在视网膜母细胞瘤中的活化及分布研究[J].眼科新进展,2014,34(1):029.
[10]孙燕 张煦 王登廷 祝杰 郑吉琦. Livin、PTEN及MMP-9在视网膜母细胞瘤中的表达及相关性研究[J].眼科新进展,2014,34(2):135.